TY  - JOUR
AU  - García-Díaz, Mario
AU  - Špacírová, Zuzana
AU  - García-Mochón, Leticia
AU  - Espín, Jaime
PY  - 2025
DO  - 10.1007/s40258-025-00994-5
UR  - https://hdl.handle.net/10668/28558
T2  - Applied health economics and health policy.
AB  - Background: Pricing and reimbursement (P&R) systems do not normally use public investments in research and development (R&D) as criteria when negotiating the prices and reimbursement of health technologies.Objective: The objective was to find...
LA  - en
PB  - Open Mind Journals Ltd.
KW  - Costs and Cost Analysis
KW  - Public Sector
KW  - Access to Essential Medicines and Health Technologies
KW  - Technology Assessment, Biomedical
TI  - Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review.
TY  - research article
ER  -